Symposia: Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, clinical trials, adult, Non-Biological therapies, epidemiology, assays, Clinical Research, Hemoglobinopathies, pediatric, Diseases, Therapies, Adverse Events, young adult , Biological Processes, Technology and Procedures, molecular biology, Study Population, Human, molecular testing
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, clinical trials, adult, Non-Biological therapies, epidemiology, assays, Clinical Research, Hemoglobinopathies, pediatric, Diseases, Therapies, Adverse Events, young adult , Biological Processes, Technology and Procedures, molecular biology, Study Population, Human, molecular testing
Saturday, December 10, 2022: 2:00 PM-3:30 PM
278-282
(Ernest N. Morial Convention Center)
Moderators:
Russell E. Ware, Children's Hospital Medical Center
and
Raffaella Colombatti, MD, PhD, University of Padova
Disclosures:
Ware: BMS: Research Funding; Addmedica: Research Funding; Hemex Health: Research Funding; Nova Laboratories: Membership on an entity's Board of Directors or advisory committees; Novartis: Other: DSMB Chair; Editas: Other: DSMB Chair. Colombatti: Novo Nordisk: Consultancy, Membership on an entity's Board of Directors or advisory committees; Bluebird Bio: Research Funding; Novartis: Membership on an entity's Board of Directors or advisory committees; Global Blood Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; AddMedica: Membership on an entity's Board of Directors or advisory committees; Forma Therapeutics: Membership on an entity's Board of Directors or advisory committees; Vertex: Membership on an entity's Board of Directors or advisory committees.
This session will include new research and clinical trial results for hydroxyurea treatment of sickle cell anemia.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH